TSG101 Antikörper (Middle Region)
Kurzübersicht für TSG101 Antikörper (Middle Region) (ABIN925845)
Target
Alle TSG101 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Ratte (Rattus), Rind (Kuh), Huhn, Hund, Human
-
Immunogen
- TSG101 antibody was raised in rabbit using the middle region of TSG101 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
TSG101 Blocking Peptide, (ABIN5616825), is also available for use as a blocking control in assays to test for specificity of this TSG101 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Andere Bezeichnung
- TSG101
-
Hintergrund
- TSG101 has a direct role in the control of growth and differentiation in primary epithelial cells. It is required for normal cell function of embryonic and adult tissues but that this gene is not a tumor suppressor for sporadic forms of breast cancer. Synonyms: Polyclonal TSG101 antibody, Anti-TSG101 antibody.
Target
-